Location
United States, North America
Cheque size
$1M - $75M
Investment Stage
Series A
Focus Areas
AI
Health IT
Health & Hospital Services
BioTech
Medical Devices
About Investor
Matthew Rizzo is a General Partner at OrbiMed and leads the firm’s Royalty and Credit Opportunities team. He joined OrbiMed in 2010 and helped launch its first dedicated royalty and credit fund. Rizzo has led more than $6 billion of investments in structured credit and royalty transactions. Before joining the firm, he was responsible for pharmaceutical licensing and acquisitions at Ikaria.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.